Recent news on Abacavir

GlaxoSmithKline, Brazil Expected To Sign Deal On Providing ...  -  May 15, 2007
Medical News Today (press release),GlaxoSmithKline and Brazil by Friday are expected to sign an agreement that would reduce the cost of GSK's antiretroviral Abacavir by 27% in the country,

AIDS Healthcare Foundation Counters GlaxoSmithKline Ads That ...  -  May 23, 2007
PR-Inside.com (Pressemitteilung),...is to educate patients on harmful side effects of HIV treatment, it should also include information on abacavir hypersensitivity reactions,

Recurring themes  -  May 16, 2007
Science Business (subscription),Already, GSK has announced it will sign a deal with Brazil, reducing the price of its Abacavir by close to 30 per cent. The billion-dollar question is

Clinton Foundation announces new price cuts for tenofovir and ...  -  May 9, 2007
Aidsmap,Abacavir, a second-line nucleoside analogue, will be available at $331 a year, compared to an average price of $750-$800 paid recently, while another

Mining Medical Records To Improve Drug Safety  -  May 7, 2007
Medical News Today (press release),The team also explains how more than half of Caucasian HIV/AIDS patients who suffer side-effects caused by the antiviral drug abacavir carry a SNP that

Africa: Q&A on Second-Line HIV/Aids Treatment  -  May 8, 2007
AllAfrica.com,The average price reduction for the seven formulations of the key second-line ARVs abacavir, didanosine, lopinavir/ritonavir, and tenofovir is 27% for low

FDA Grants Tentative Approval for Matrix's Antiretroviral Drug ...  -  Apr 12, 2007
Kaiser network.org,India-based Matrix Laboratories recently received tentative approval from FDA to produce 300 milligram tablets of the antiretroviral drug abacavir sulfate,

FDA Announces Tentative Approval of Generic Abacavir Sulfate Tablets  -  Apr 6, 2007
PharmaLive.com (press release),Abacavir sulfate is a member of the class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which help keep the AIDS virus from

Speed of viral load decline is a sign of more effective ...  -  Apr 18, 2007
Aidsmap,A5095 established the superiority of the efavirenz-containing regimen to the triple-nucleoside abacavir-containing regimen (Gulick 2004; Gulick 2006).

FDA Announces Important Notice About Combivir and Ziagen  -  Apr 10, 2007
PharmaLive.com (press release),We would like to call to your attention an apparent third-party tampering that caused misbranding of Ziagen® (abacavir sulfate) Tablets as Combivir®

FDA Alerts Pharmacists About Mislabeling of HIV Drugs  -  Apr 11, 2007
MedPage Today,A letter sent to pharmacists said the incidents, which involved abacavir sulfate (Ziagen) and a combination of lamvudine and zidovudine (Combivir),

Isolated Case of Counterfeit Combivir on the Market  -  Apr 12, 2007
Facts and Comparisons,GlaxoSmithKline is informing health care professionals of an incident of misbranding of Ziagen (abacavir sulfate) as Combivir (lamivudine/zidovudine).

The Top 14 Most Counterfeited Medications  -  Mar 28, 2007
ScienceBlogsTrizivir (abacavir/lamivudine/zidovudine - used in the treatment of HIV). 12. Viagra (sildenafil - you know this one for sure)

Adverse effects of ARVs  -  Apr 1, 2007
ZimDaily,Some examples of drugs in this class: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, and abacavir. Common side effects for the class: fat

Update on Opt-Out Testing and Initial Antiretroviral Therapy ...  -  Apr 2, 2007
Medscape (subscription)...primarily abacavir (ABC)/lamivudine (3TC) or tenofovir (TDF)/emtricitabine (FTC). There was little new information at the meeting to change this.

Narrative Review: Antiretroviral Therapy to Prevent the Sexual ...  -  Apr 16, 2007
Annals of Internal MedicinePenetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1. Clin Infect Dis.

Data Published In AIDS Show Viramune (nevirapine) Achieves Durable ...  -  Feb 5, 2007
Medical News Today (press release),Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a protease inhibitor-based regimen to a

Data published in AIDS show Viramune® (nevirapine) achieves ...  -  Jan 31, 2007
Newsdesk,Ingelheim/Germany, 31 January 2007 - Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a

Data Published in AIDS Show Viramune(R) (nevirapine) Achieves ...  -  Jan 31, 2007
campus med,Patients were then randomized to replace their protease inhibitor with VIRAMUNE twice daily (n=155), efavirenz once daily (n=156) or abacavir twice daily

Data Published in AIDS Show Viramune(R) (nevirapine) Achieves ...  -  Jan 31, 2007
Earthtimes.orgLong-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) studydemonstrate that patients who switched from a protease inhibitor-basedregimen to a

Boehringer Says Study Supports its AIDS Drug  -  Jan 26, 2007
Therapeutics Daily (subscription) (press release),Ingelheim's nevirapine or Bristol-Myers Squibb's efavirenz drugs than to GlaxoSmithKline's abacavir, according to a study, Boehringer said on Friday.

APS: Data Published in AIDS Show Viramune(R) (nevirapine) ........  -  Jan 31, 2007
ANP Pers Support,...in the abacavir and VIRAMUNE arms occurred in the first weeks of the study. The most. rash in the VIRAMUNE arm. While in the VIRAMUNE group adverse events

Public standards for world medications to treat neglected ...  -  Jan 29, 2007
News-Medical.net,The initial two drugs included in the International Standards program are used in the treatment of HIV-AIDS: Abacavir Sulfate, and Efavirenz.

HIV medicine funding positive start to New Year  -  Dec 20, 2006
Scoop.co.nz (press release),A new once-daily HIV medication Kivexa™ (abacavir/lamivudine), which combines two antiretrovirals in one tablet, will be fully funded from January 1st 2007.

Four into one for new HIV TREATMENT  -  Dec 20, 2006
Scoop.co.nz (press release),In the latest decision concerning HIV medicines, the government drug-buying agency will fund fixed-dose abacavir and lamivudine (Kivexa) from January 1,

HIV sufferers get combined pill  -  Dec 21, 2006
New Zealand Herald,It contains two medicines already subsidised for people with HIV, abacavir and lamivudine. The Aids Foundation welcomed the change, but warned that

Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow  -  Dec 26, 2006
Medscape (subscription)However, no more than 40% of suspected abacavir HSRs are ultimately reported in persons who have this allele, suggesting that more than half of these

More fixed dose ARVs for children needed urgently, says WHO  -  Jan 9, 2007
Aidsmap,Scored abacavir and nevirapine tablets are also highlighted as urgent. The WHO panel is also calling on international regulatory authorities,

Antiretroviral Therapy for HIV: New Data From HIV 8 in Glasgow  -  26 Dec 2006
Medscape (subscription)However, no more than 40% of suspected abacavir HSRs are ultimately reported in persons who have this allele, suggesting that more than half of these

HIV medicine funding positive start to New Year  -  Dec 20, 2006
Scoop.co.nz (press release),A new once-daily HIV medication Kivexa™ (abacavir/lamivudine), which combines two antiretrovirals in one tablet, will be fully funded from January 1st 2007.

Four into one for new HIV TREATMENT  -  Dec 20, 2006
Scoop.co.nz (press release),In the latest decision concerning HIV medicines, the government drug-buying agency will fund fixed-dose abacavir and lamivudine (Kivexa) from January 1,

HIV sufferers get combined pill  -  Dec 21, 2006
New Zealand Herald,It contains two medicines already subsidised for people with HIV, abacavir and lamivudine. The Aids Foundation welcomed the change, but warned that

FDA Safety Changes: Ortho Evra, Avastin, Trizivir  -  Dec 13, 2006
Medscape (subscription)On August 11, the FDA approved safety labeling revisions for abacavir sulfate/lamivudine/zidovudine tablets (Trizivir, made by GlaxoSmithKline) to warn of

Triple nuke combination of AZT/3TC/tenofovir below current ...  -  Dec 17, 2006
Aidsmap,Despite reports emerging in 2003 that tenofovir/3TC in combination with abacavir (Ziagen) or ddI (didanosine, Videx/Videx EC) had a high rate of early

HIV/AIDS: 2nd line of treatment too costly, no Govt policy yet  -  Nov 29, 2006
Indian Express,These include improved drugs like Tenofavir and Abacavir. “I have two options — to live and pay huge amounts every month or just prepare to die,’’ said

96-Week Data From Gilead’s Study 934 Comparing Viread ® and ...  -  Dec 15, 2006
Business Wire (press release),...(lamivudine/zidovudine), Epivir ® (lamivudine), Epivir-HBV ® , Epzicom TM (abacavir/lamivudine), or Trizivir ® (abacavir/lamivudine/zidovudine).

96-Week Data From Gilead's Study 934 Comparing Viread and Emtriva ...  -  Dec 15, 2006
PharmaLive.com (press release),...(lamivudine/zidovudine), Epivir(R) (lamivudine), Epivir-HBV(R), Epzicom(TM)(abacavir/lamivudine), or Trizivir(R) (abacavir/lamivudine/zidovudine).

Second line HIV treatment a reality?  -  Dec 1, 2006
Times of India,Public pharma companies have been approached to see whether they can supply second line drugs like Tenofovir, Abacavir and Retanovir cheaper.

Breakthrough deal signed for paediatric HIV drugs  -  Dec 1, 2006
Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.

Me and AIDS: Happy Anniversary!  -  Nov 30, 2006
Gay City NewsAnother time, I wound up in the hospital puffed up like a giant red lobster boy following an allergic reaction to Abacavir. That was fun.

President Clinton Announces Breakthroughs In HIV/AIDS Treatment ...  -  Nov 30, 2006
Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,

Second generic abacavir approved for PEPFAR  Nov 7, 2006
A generic version of the nucleoside analogue abacavir, manufactured by Cipla, has received tentative approval from the US Food and Drug Administration. ... -Aidsmap, FDA List Serve - Tentative approval of generic abacavir sulfate  Nov 7, 2006
6, 2006--The Food and Drug Administration, on November 6, 2006, granted tentative approval for a generic formulation of abacavir sulfate tablets, 300 mg ... -PharmaLive.com (press release), New Data Reinforce Efficacy of Abacavir Sulfate/Lamivudine ...  Oct 12, 2006
SAN FRANCISCO, CA -- October 12, 2006 -- The HIV medication Trizivir(R) (abacavir sulfate, lamivudine, and zidovudine) administered twice daily provides ... -DG News Management of Antiretroviral Toxicities and HCV Coinfection  Nov 2, 2006
Abacavir and nevirapine are 2 potent, generally well-tolerated drugs whose use is complicated by the risk for hypersensitivity reactions (HSR) at the ... Abacavir. ... -Medscape (subscription) Cipla receives tentative approval from US for AIDS drug  Nov 7, 2006
Cipla (Q, N,C,F)* has received tentative approval from the US Food and Drug Administration to sell AIDS drug `abacavir sulfate` in tablet form, reports ... -Myiris.com, Antiretroviral Treatment Strategies for Adults With HIV  Nov 2, 2006
The ACTION Study [15] compared the triple-NRTI regimen of zidovudine (ZDV)/lamivudine (3TC)/abacavir (ABC) twice daily with a novel regimen of ZDV/3TC twice ... -Medscape (subscription) In resource limited settings, second-line strategies need to be ...  Oct 16, 2006
More treatment options, especially abacavir and tenofovir, will be needed for effective second-line treatment strategies in these countries. ... -Aidsmap, GlaxoSmithKline and Vertex Pharmaceuticals Announce Virologic and ...  Oct 12, 2006
Lexiva with Epivir(R) (lamivudine) and Abacavir in ART-Naive patients) were also presented at the International AIDS Conference in Toronto in August 2006. ... -DG News Brain-protecting medicines for HIV a research priority  Oct 17, 2006
A few of today’s HIV-suppressing drugs, such as nevirapine, abacavir, AZT and indinavir, can penetrate the blood-brain barrier. ... -Wilkes Barre Times-Leader, Scientists battle HIV dementia  Oct 16, 2006
A few of today's HIV-suppressing drugs, such as nevirapine, abacavir, AZT and indinavir, can penetrate the blood-brain barrier, says Dr. Ron Ellis of the ... -Indianapolis Star, Antiretroviral Treatment Strategies for Adults  Sep 22, 2006
...ritonavir (700/100 mg twice daily; fosAPV/r) vs lopinavir/ritonavir (400/100 mg twice daily; LPV/r) combined with fixed-dose abacavir/lamivudine given once ... -Medscape (subscription)

Catatonia After Liver Transplantation  Sep 7, 2006
10 In another case of catatonia, a 37-year-old woman with HIV infection was taking abacavir, nevirapine, and combivir; cessation of antiretrovirals and ... -Psychosomatics (subscription)

HIV/AIDS: 2nd line of treatment too costly, no Govt policy yet  -  Nov 26, 2006
Indian Express,These include improved drugs like Tenofavir and Abacavir. “I have two options — to live and pay huge amounts every month or just prepare to die,’’ said

Tenofovir kidney toxicity: real, but uncommon and usually reversible  -  Nov 21, 2006
Aidsmap,Poster 150 (Smith) compared the risks of certain toxicities between patients taking TDF and ones taking the alternative NRTI drug abacavir (ABC).

Second line HIV treatment a reality?  -  Dec 1, 2006
Times of India,Public pharma companies have been approached to see whether they can supply second line drugs like Tenofovir, Abacavir and Retanovir cheaper.

Breakthrough deal signed for paediatric HIV drugs  -  Dec 1, 2006
Pharma Times (subscription),The other ARVs for which the Clinton Foundation has negotiated price reductions include abacavir, didanosine, efavirenz and zidovudine.

Me and AIDS: Happy Anniversary!  -  Nov 30, 2006
Gay City NewsAnother time, I wound up in the hospital puffed up like a giant red lobster boy following an allergic reaction to Abacavir. That was fun.

President Clinton Announces Breakthroughs In HIV/AIDS Treatment ...  -  Nov 30, 2006
Medical News Today (press release),In addition to the three ARVs included in the pediatric FDC, the other ARVs for which CHAI has negotiated price reductions include abacavir, didanosine,



Glaxo-Vertex Study tests anti-HIV drugs  16 May 2006
Patients in both groups were also given 600 milligrams of abacavir and 300 milligrams of lamivudine, the active ingredients in GlaxoSmithKline's HIV drugs ... - BusinessWeek

HIV Pharmacology Workshop: Explaining the genetic basis of AZT ...  May 1, 2006
Simon Mallal from Perth who first characterised B*5701, the ancestral haplotype correlated with abacavir hyper-sensitivity reaction (ABC HSR), presented an ... - Aidsmap





New Antiretroviral Strategies for First-Line and "Switch" Patients ...  Mar 22, 2006
The NORA study [8] is a double-blinded, placebo-controlled trial that compares the safety and efficacy of abacavir or nevirapine with fixed dose zidovudine ... - Medscape (subscription)

Rare resistance mutation, K65N, means that multiple NRTIs don't ...  Mar 26, 2006
2003 and started antiretroviral therapy consisting of the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz (Sustiva), abacavir (Ziagen) and 3TC ... - Aidsmap

GlaxoSmithKline Joins Combined White House, Industry, UN Agencies ...  Mar 13, 2006
...the company has committed to support a study in Botswana for the prevention of MTCT, which is the first GSK-supported study investigating abacavir in pregnancy ... - Finanzen.net

HIV services face unprecedented cuts  Mar 22, 2006
...treatment decisions that had already been considered by the London consortium, such as putting all possible patients on to Kivexa® (abacavir/3TC) in place of ... - Gay.com UK

Study finds no link between brain-penetrating antiretroviral drugs ...  Mar 21, 2006
Previous studies have shown that these are AZT (zidovudine, Retrovir), d4T (stavudine, Zerit), 3TC (lamivudine, Epivir), abacavir (Ziagen), nevirapine (Viramune ... - Aidsmap

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional